# A Pilot Trial to Test the Feasibility of Utilizing Home Blood Pressure Monitoring to Optimize the Administration of Midodrine Among Decompensated Cirrhosis Patients

> **NCT05928624** · NA · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 69 (actual)

## Conditions studied

- Cirrhosis, Liver
- Portal Hypertension
- Ascites Hepatic

## Interventions

- **DEVICE:** Withings Home Blood Pressure Device and Scale
- **OTHER:** Standard of Care

## Key facts

- **NCT ID:** NCT05928624
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-22
- **Primary completion:** 2024-07-01
- **Final completion:** 2024-07-01
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2025-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05928624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05928624, "A Pilot Trial to Test the Feasibility of Utilizing Home Blood Pressure Monitoring to Optimize the Administration of Midodrine Among Decompensated Cirrhosis Patients". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05928624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*